Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

Single Center Experience Using Monoclonal COVID-19 Antibodies in the Management of Immunocompromised Patients with COVID-19

The medical care of immunocompromised patients with COVID-19 infection causes major hurdles in the management of these patients in clinical practice. However, poor responses to vaccinations in patients with oncological or autoimmune diseases require rapid action and effective care in this fragile pa...

Full description

Bibliographic Details
Main Authors: David Klank, Bernd Claus, Raoul Bergner, Peter Paschka
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Microorganisms
Subjects:
COVID-19
monoclonal antibodies
vaccination
immunosuppressed patients
Online Access:https://www.mdpi.com/2076-2607/10/12/2490

Similar Items

Similar Items